Building a modern competitive and market intelligence function in life sciences.
Competitive and market intelligence functions in life sciences are being asked to move faster, cover more, and feed decisions that used to sit upstream. The cycle time has collapsed. Five years ago, the response window to a competitor filing or trial readout was measured in months. Today it runs in days, sometimes hours.
The bottleneck is not access to content. It is fragmentation. Signals live in SharePoint, email, direct messages, vendor portals, conference notes, and the heads of people who attended a session in Barcelona last week. Analysts spend most of their time gathering rather than synthesizing, and by the time insight reaches a decision maker, the window has often closed.
What's inside the paper
That pulls external, licensed, primary, and internal signals into one connected place instead of leaving them scattered across tools and inboxes.
Built with source traceability and content-provider permissions as first-class requirements, so analysts synthesize at speed without compromising compliance.
That puts insight into the workflow where decisions actually get made — email, Slack, Teams, and Copilot — not in a portal no one opens.
$5M+
annualized productivity gains at a top-five global pharma
3×
faster signal to decision on a unified platform
15,000
users consolidated onto a single intelligence environment
FAQ
One unified environment that pulls external, licensed, primary, and internal signals together; responsible AI that respects content-provider permissions and source traceability; and delivery into the tools where decisions are actually made, such as email, Slack, Teams, and Copilot.
By treating source traceability and content-provider permissions as first-class requirements, so analysts synthesize at speed while every output stays cited and compliant.
Signals are scattered across SharePoint, email, direct messages, vendor portals, and conference notes, so analysts spend most of their time gathering rather than synthesizing, and insight often arrives after the decision window has closed.
Competitive and market intelligence teams in pharma and biotech. Northern Light supports C&MI infrastructure for fourteen of the top fifteen global pharmaceutical companies.